Showing 601 - 620 results of 933 for search '"rheumatologist"', query time: 4.04s Refine Results
  1. 601

    Stressors and depressive disorders in rheumatic diseases by Tatyana Andreyevna Lisitsyna, D Yu Veltishchev, E L Nasonov

    Published 2013-04-01
    “…By taking into account the importance of detection and treatment of depressive disorders in rheumatologic practice from the clinical standpoint and in terms of medical, social, and economic consequences, the author propose an interdisciplinary approach to managing the patients with RD with the participation of rheumatologists, psychiatrists, neurologists, and medical psychologists.…”
    Get full text
    Article
  2. 602

    THE CONCEPT OF BARRIER ORGAN DISEASE IN THE PATHOGENESIS OF SPONDYLOARTHRITIS by E. A. Galushko, A. V. Gordeev

    Published 2016-07-01
    “…An update on cellular and molecular mechanisms in the pathogenesis of SpA permits rheumatologists to offer a hypothesis of the concept of barrier organ disease as a preclinical stage of the diseases included in the SpA group. …”
    Get full text
    Article
  3. 603

    Multisystem lesions in orphan diseases: rheumatological aspects of Fabry's disease. Case report by Olga V. Mashkunova, Asel H. Isabekova, Aigerim Z. Botabekova, Pavel I. Novikov

    Published 2023-08-01
    “…The article presents a clinical observation of the classical type of Fabry disease with multiple organ manifestation, which required differential diagnosis with rheumatological diseases. Rheumatologists are specialists who are involved in the early diagnosis of Fabry disease, so they should have a high awareness of this sphingolipidosis.…”
    Get full text
    Article
  4. 604

    New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria<sup>®</sup>) Vaccine Administration by Luca Lo Sardo, Simone Parisi, Maria Chiara Ditto, Rosanna De Giovanni, Francesca Maletta, Serena Grimaldi, Luisa Brussino, Enrico Fusaro

    Published 2023-02-01
    “…Although the overall incidence of vaccine-triggered autoimmunity is low, rheumatologists worldwide should be aware of autoimmune diseases as a new potential adverse event of vaccines.…”
    Get full text
    Article
  5. 605

    Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician–Patient Communication by Amal Aldarwesh, Ali Almustanyir, Mazoon Alharthi, Duja Alhayan

    Published 2022-11-01
    “…Knowledge obtained from physicians’ communication may improve the health outcomes of chronically ill patients. Rheumatologists and ophthalmologists should work together to recognize patients at risk of hydroxychloroquine toxicity and ensure they receive proper education and adhere to periodic follow-up.…”
    Get full text
    Article
  6. 606

    MRI in Axial Spondyloarthritis: Position Statements from the Hong Kong Society of Rheumatology by Ho Yin Chung, Priscilla Ching Han Wong, Kam Ho Lee, Natalia Chu-Oi Ciang, Stella Pui Yan Wong, Peng Cao, Shirley Chiu Wai Chan, Vince Wing Hang Lau, Bill Archie Lo, Ryan Ka Lok Lee

    Published 2022-07-01
    “…These statements have at least 75% agreement from voting rheumatology fellows of HKSR, and are developed to serve as local practice guidelines for rheumatologists and musculoskeletal radiologists in the management of axSpA.…”
    Get full text
    Article
  7. 607

    Angiotensins and rheumatoid arthritis by N. M. Savushkina, E. A. Galushko, N. V. Demidova, A. V. Gordeev

    Published 2019-01-01
    “…It is of fundamentally importance for rheumatologists to affect inflammation, including rheumatoid inflammation, through blockade of angiotensin (AT) II formation via the effects of AT 1–7 and angiotensin-converting enzyme inhibitors, as well as through suppression of angiogenesis, primarily by reducing the production of endothelial growth factor. …”
    Get full text
    Article
  8. 608

    Unilateral CRAO as the presenting clinical sign of systemic lupus erythematosus by Yuli Lim, Elahhe Rebecca Afkhamnejad, Shaheen Kavoussi

    Published 2023-03-01
    “…Awareness of this risk may play a factor in future discussions between patients and their rheumatologists when considering initiation of treatment at the time of diagnosis.…”
    Get full text
    Article
  9. 609

    Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19 by Xiaoxuan Sun, Yicheng Ni, Miaojia Zhang

    Published 2020-01-01
    “…Given the fact that for decades HCQ has been approved as an immunomodulatory drug for the long term treatment of chronic rheumatic diseases, as experienced rheumatologists, we would like to share our thoughts in this regard and trigger a brainstorm among clinical care providers for exchanging their diverse opinions on this urgent topic.…”
    Get full text
    Article
  10. 610

    Hereditary periodic fever syndromes in adult rheumatology practice by O. V. Zhelyabina, M. S. Eliseev, M. N. Chikina

    Published 2018-04-01
    “…However, due to the clinical introduction of new diagnostic techniques, primarily  genetic ones, and drug therapy in the detection and treatment of  these diseases, there has been clear progress, which makes it possible to change long-term prognosis in AIDs and to arouse increasing interest in the diseases not only among pediatricians, geneticists, but also among rheumatologists and general practitioners.…”
    Get full text
    Article
  11. 611

    PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS by V. N. Amirdzhanova, M. A. Makarov, E. I. Byalik, S. A. Makarov, M. M. Lipina

    Published 2014-09-01
    “…The paper considers the joint management of rheumatoid arthritis patients needing endoprosthetic replacement of the large joints of the lower extremities by rheumatologists and orthopedic traumatologists.Due to the fact that there are no conventional standards or guidelines for the perioperative management of patients with rheumatic diseases, adopted by international rheumatology associations, the authors generalize their experience in managing the patients in terms of international approaches and guidelines from different countries. …”
    Get full text
    Article
  12. 612

    Current state of diagnostic and treatment of osteoporosis in real-life clinical practice (a pilot study) by O.A. Nikitinskaya, N.V. Toroptsova

    Published 2014-05-01
    “…A pilot survey among physicians demonstrated that experts (rheumatologists, endocrinologists, etc.) have a high level of awareness of the OP problem and successfully use this knowledge in daily practice (modern diagnosis, prevention, and treatment methods). …”
    Get full text
    Article
  13. 613

    PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC CONNECTIVE TISSUE DISEASES: THE CURRENT STATE OF THE PROBLEM by A. V. Volkov, T. V. Martynyuk

    Published 2018-09-01
    “…The purpose of the lecture is to acquaint rheumatologists with the possibilities of diagnosis and treatment of this rare, but prognostic severe manifestation of SCTDs.…”
    Get full text
    Article
  14. 614

    Effects of autoimmune disorders on daily lifestyle by Kinga Kawałko, Grzegorz Rynio, Kamil Pondel, Anna Karaś, Krzysztof Bielewicz, Patrycja Sufin

    Published 2022-11-01
    “…Neuropsychiatric complications in systemic connective tissue diseases are of interest to both neurologists and rheumatologists and specialists in other fields. These complications may occur with different frequency – from 30-80% and result from the involvement of individual structures of the central and peripheral nervous system. …”
    Get full text
    Article
  15. 615

    X-ray diagnosis of juvenile chronic oligoarthritis by Aleksei N. Kozhevnikov, Nina A. Pozdeeva, Mikhail A. Konev, Olga N. Maricheva, Konstantin A. Afonichev, Gennadiy A. Novik

    Published 2017-10-01
    “…This article aims at systematizing and expanding the views of pediatricians and rheumatologists on the importance of radiography methods in the diagnosis of joint pathology in children.…”
    Get full text
    Article
  16. 616

    INFLIXIMAB IN TREATMENT OF ACTIVE JUVENILE ARTHRITIS by E. S. Zholobova, O. Yu. Konopel'ko, D. V. Dagbaeva, A. V. Bunin, O. S. Rozvadovskaya, M. N. Nikolaeva, V. Ya. El'yashevich

    Published 2012-05-01
    “…By the 12 th month of the observation all the patients in these groups have achieved good results, corresponding with 70 % of improvement according to pediatric criteria of the American College of Rheumatologists. In patients with systemic arthritis a moderate positive effect was seen in first two months of treatment. …”
    Get full text
    Article
  17. 617

    Juvenile Psoriatic Arthritis: Myth or Reality? An Unending Debate by Roberta Naddei, Ana Rebollo-Giménez, Marco Burrone, Valentina Natoli, Silvia Rosina, Alessandro Consolaro, Angelo Ravelli

    Published 2023-01-01
    “…Juvenile psoriatic arthritis (JPsA) accounts for 1–7% of all cases of juvenile idiopathic arthritis (JIA) and its definition has been a matter of controversy among pediatric rheumatologists for many years. The traditional attribution of JPsA to the spondyloarthropathy group was challenged in the early 1990s, whereas the recent demonstrations of its heterogenous nature have led to questions about its identification as a distinct category in JIA classification. …”
    Get full text
    Article
  18. 618

    A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. by Taylor, P, Moore, A, Vasilescu, R, Alvir, J, Tarallo, M

    Published 2016
    “…While rheumatologists often focus on treatment targets, for many patients with rheumatoid arthritis (RA), control over pain and fatigue, as well as sustaining physical function and quality of life (QoL), is of primary importance. …”
    Journal article
  19. 619

    EXPERIENCE OF TREATMENT OF THE TWINS SICK WITH JUVENILE IDIOPATHIC ARTHRITIS BY ABATACEPT by V. A. Kel'tsev

    Published 2014-05-01
    “…In 6 weeks of the treatment 50% improvement, in 24 weeks — 90% improvement by criteria of the American College of Rheumatologists (ACRpedi) were registered. The undesirable phenomena weren’t observed.…”
    Get full text
    Article
  20. 620

    When and how should we use imaging in individuals at risk of rheumatoid arthritis? by Kate Harnden, Andrea Di Matteo, Kulveer Mankia

    Published 2022-11-01
    “…In recent years rheumatologists have begun to shift focus from early rheumatoid arthritis (RA) to studying individuals at risk of developing the disease. …”
    Get full text
    Article